Common use of Aplastic Anemia Clause in Contracts

Aplastic Anemia. Chronic persistent bone marrow failure which results in anaemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following: i. Repeated blood transfusions; ii. Marrow stimulating agents; iii. Immunosuppressive agents; or iv. Bone marrow transplant The diagnosis of irreversible aplastic anemia must be confirmed by a Hematologist acceptable to the Company. Two out of the following three values must be present: 1. Absolute neutrophil count of 500 per cubic millimeter or less; 2. Reticulocyte count of 20,000 per cubic millimeter or less; 3. Platelet count of 20,000 per cubic millimeter or less. a. Temporary or reversible aplastic anemia is excluded and not covered in this Policy.

Aplastic Anemia. Chronic persistent bone marrow failure which results in anaemiaanemia, neutropenia and thrombocytopenia requiring treatment with at least one of the following: i. (i) Repeated blood transfusions; (ii. ) Marrow stimulating agents; (iii. ) Immunosuppressive agents; or (iv. ) Bone marrow transplant The diagnosis of irreversible aplastic anemia must be confirmed by a Hematologist acceptable to the Company. Two out of the following three values must be present: 1. Absolute neutrophil count of 500 per cubic millimeter or less; 2. Reticulocyte count of 20,000 per cubic millimeter or less; 3. Platelet count of 20,000 per cubic millimeter or less. a. . Temporary or reversible aplastic anemia is excluded and not covered in this Policyanemia.